Patients
MAY
Between May 2015 and March 2018, 207 patients were screened for study entry and provisionally registered. After a central review of the MMSE and CDR results, 166 patients (mean [SD] age, 75.6 [5.2] years) were enrolled and randomly allocated to the cilostazol or placebo group (